Short-circuiting autoimmune disease by target-tissue-derived nitric oxide

Area of Science:

• Immunology
• Neuroscience
• Molecular Biology

Background:

• Previous research linked skeletal muscle inducible nitric oxide synthase (iNOS) expression to resistance in an experimental autoimmune myasthenia gravis (MG) model.
• The model involves Wistar Furth rats receiving antibodies against the nicotinic acetylcholine receptor (AChR).

Purpose of the Study:

• To investigate the association between iNOS/NO expression and programmed cell death (apoptosis) in immune cells during experimental MG.
• To determine the role of muscle-derived NO in the immunopathology of experimental MG.

Main Methods:

• Induction of experimental myasthenia gravis (MG) in Wistar Furth rats via passive antibody transfer (anti-AChR).
• Assessment of inducible nitric oxide synthase (iNOS)/nitric oxide (NO) expression within skeletal muscles.
• Evaluation of apoptosis in macrophages and CD4+ T cells trafficking through affected muscles.

Main Results:

• Increased expression of iNOS/NO was observed in Wistar Furth rats with experimental MG.
• This increased iNOS/NO expression correlated with the induction of apoptosis in infiltrating macrophages and CD4+ T cells.
• Muscle-targeted immune cell infiltration was associated with iNOS/NO-induced apoptosis.

Conclusions:

• Muscle-derived nitric oxide (NO) production plays a protective role in experimental myasthenia gravis (MG).
• NO-mediated apoptosis of immune cells contributes to reduced immunopathology.
• The level of muscle-derived NO influences the overall severity of experimental MG.